Frequency and disease severity of familial mediterranean fever (FMF) related MEFV gene mutations among ankylosing spondylitis patients;Ankilozan spondilit hastalari{dotless}nda mefv (mediterranean fever) gen mutasyonlari{dotless} si{dotless}kli{dotless}ǧi{dotless}ni{dotless}n ve hastali{dotless}k şiddeti üzerine etkisinin deǧerlendirilmesi

Turkiye Klinikleri Journal of Medical Sciences

Volumn 34, Issue 2, 2014, Pages 223-230

  Tufan, Asli ^a   Aydin, Sibel Zehra ^b   Eren, Fatih ^c   Atagündüz, Pamir ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Faculty of Medicine   (Turkey)

^c MARMARA UNIVERSITY   (Turkey)

Author keywords

Ankylosing; Familial mediterranean fever; Spondylitis

Indexed keywords

HLA B27 ANTIGEN;

AMPLIFICATION REFRACTORY MUTATION SYSTEM METHOD; ANKYLOSING SPONDYLITIS; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; BATH ANKYLOSING SPONDYLITIS RADIOLOGY INDEX; BEHCET DISEASE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE; GENE MUTATION; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MEFV GENE; MODIFIED STOKES ANKYLOSING SPONDYLITIS SPINE SCORE; MORBIDITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; POLYMERASE CHAIN REACTION; RADIOGRAPHY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS;

EID: 84901676835     PISSN: 13000292     EISSN: None     Source Type: Journal    
DOI: 10.5336/medsci.2013-34490     Document Type: Article

References (29)

1. Märker-Hermann E, Höhler T. Pathogenesis of human leukocyte antigen B27-positive arthritis. Information from clinical materials. Rheum Dis Clin North Am 1998;24(4):865-81, xi.
2. French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997;17(1):25-31.
3. Balow JE Jr, Shelton DA, Orsborn A, Mangelsdorf M, Aksentijevich I, Blake T, et al. A high-resolution genetic map of the familial Mediterranean fever candidate region allows identification of haplotype-sharing among ethnic groups. Genomics 1997;44(3):280-91.
4. Bertin J, DiStefano PS. The PYRIN domain: a novel motif found in apoptosis and inflammation proteins. Cell Death Differ 2000;7(12): 1273-4.
5. Rabinovich E, Livneh A, Langevitz P, Brezniak N, Shinar E, Pras M, et al. Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis 2005;64(7):1009-14.
6. Rozenbaum M, Rosner I. Severe outcome of juvenile idiopathic arthritis (JIA) associated with familial Mediterranean fever (FMF). Clin Exp Rheumatol 2004;22(4 Suppl 34):S75-8.
7. Atagunduz P, Ergun T, Direskeneli H. MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement. Clin Exp Rheumatol 2003;21(4 Suppl 30):S35-7.
8. Touitou I, Magne X, Molinari N, Navarro A, Quellec AL, Picco P, et al. MEFV mutations in Behçet's disease. Hum Mutat 2000;16(3):271-2.
9. Shinar Y, Livneh A, Villa Y, Pinhasov A, Zeitoun I, Kogan A, et al. Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients. Genes Immun 2003;4(3):197-203.
10. Fidder H, Chowers Y, Ackerman Z, Pollak RD, Crusius JB, Livneh A, et al. The familial Mediterranean fever (MEVF) gene as a modifier of Crohn's disease. Am J Gastroenterol 2005; 100(2):338-43.
11. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27(4): 361-8.
12. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40(10):1879-85.
13. MacKay K, Mack C, Brophy S, Calin A. The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum 1998;41(12): 2263-70.
14. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21(12):2281-5.
15. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21(12):2286-91.
16. Medlej-Hashim M, Loiselet J, Lefranc G, Mégarbané A. [Familial Mediterranean Fever (FMF): from diagnosis to treatment]. Sante 2004;14(4):261-6.
17. Onen F, Akar S, Birlik M, Sari I, Khan MA, Gurler O, et al. Prevalence of ankylosing spondylitis and related spondyloarthritides in an urban area of Izmir, Turkey. J Rheumatol 2008;35(2):305-9.
18. Meyerhoff J. Familial Mediterranean fever: report of a large family, review of the literature, and discussion of the frequency of amyloidosis. Medicine (Baltimore) 1980;59(1):66-77.
19. Yilmaz E, Balci B, Kutlay S, Ozen S, Ertürk S, Oner A, et al. Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients. Turk J Pediatr 2003;45(3):198-202.
20. Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, et al.; Turkish FMF Study Group. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 2005; 84(1):1-11.
21. Direskeneli H, Gül A. ISBD basic research perspectives. A preliminary "outline " for basic research workshop studies. Adv Exp Med Biol 2003;528:293-9.
22. Fei Y, Webb R, Cobb BL, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH. Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study. Arthritis Res Ther 2009;11(3):R66.
23. Pham T. Pathophysiology of ankylosing spondylitis: what's new? Joint Bone Spine 2008;75(6):656-60.
24. Atagunduz P, Appel H, Kuon W, Wu P, Thiel A, Kloetzel PM, et al. HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis. Arthritis Rheum 2005;52(3):892-901.
25. Karban A, Dagan E, Eliakim R, Herman A, Nesher S, Weiss B, et al. Prevalence and significance of mutations in the familial Mediterranean fever gene in patients with Crohn's disease. Genes Immun 2005;6(2):134-9.
26. Durmus D, Alayli G, Cengiz K, Yigit S, Canturk F, Bagci H. Clinical significance of MEFV mutations in ankylosing spondylitis. Joint Bone Spine 2009;76(3):260-4.
27. Cinar M, Dinc A, Simsek I, Erdem H, Koc B, Pay S, et al. The rate and significance of Mediterranean fever gene mutations in patients with ankylosing spondylitis: a three-month, longitudinal clinical study. Rheumatol Int 2008;29(1):37-42.
28. Cosan F, Ustek D, Oku B, Duymaz-Tozkir J, Cakiris A, Abaci N, et al. Association of familial Mediterranean fever-related MEFV variations with ankylosing spondylitis. Arthritis Rheum 2010;62(11):3232-6.
29. Akkoc N, Sari I, Akar S, Binicier O, Thomas MG, Weale ME, et al. Increased prevalence of M694V in patients with ankylosing spondylitis: additional evidence for a link with familial mediterranean fever. Arthritis Rheum 2010; 62(10):3059-63.